Eastman Chemical Company

SEC 8K filing, our slides, and the related prepared remarks in the investor section of our website eastman.com. Before we begin, I'll cover two items. First, during this presentation, you will hear certain forward-looking statements concerning our plans and expectations. Actual events or results could differ materially. Certain factors related to our future expectations are or will be detailed in our fourth quarter and full year 2024 financial results news release. During this call, in the preceding slides and prepared remarks and in our filings with the Securities and Exchange Commission, including the Form 10-K filed for full year 2023 and the Form 10-K to be filed for full year 2024. Second, earnings referenced in this presentation exclude certain non-core and unusual items, reconciliations to the most directly comparable GAAP financial measures and other associated disclosures, including a description of the excluded and adjusted items are available in the fourth quarter and full year 2024 financial results news release. As we posted the slides and accompanying prepared remarks on our website last night, we will now go straight into Q&A. Harry, please let's start with our first question.

Our first question will come from the line of Josh Spector with UBS. Please go ahead. Your line is open.

Hey, guys. This is James Cannon. I'm for Josh. Thanks for taking my question. I just wanted to jump in on the AM guidance. I think between the overall segment and what you're assuming for the Kingsport contribution, it seems like you're assuming a decline in the base business. And I just was wondering if you could unpack some of the moving pieces there.